Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis

Author:

Dorros Gerald1,Jaff Michael1,Mathiak Lynne1,Dorros Isa I.1,Lowe Adam1,Murphy Kelly1,He Thomas1

Affiliation:

1. From the William Dorros-Isadore Feuer Interventional Cardiovascular Disease, Foundation Ltd, Milwaukee, Wis (G.D., L.M., I.I.D., T.H.); the Arizona Heart Institute Foundation, Phoenix, Ariz (G.D.); and the Vascular Medicine and Vascular Laboratory, Integrated Cardiovascular Therapeutics, LLC, Woodbury, NY (M.J.).

Abstract

Background —Stent revascularization is perceived as superior to balloon angioplasty and surgical revascularization, but the paucity of stent publications precludes even historical comparison with surgical data. Methods and Results —Palmaz-Schatz stent revascularization of renal artery stenosis was successfully performed on 163 consecutive patients for poorly controlled hypertension or preservation of renal function. Of these, 145 were eligible for ≥6-month clinical follow-up of the effect of the procedure on renal function, blood pressure control, number of antihypertensive medications, and survival. At 4 years, systolic and diastolic blood pressures significantly decreased (from 166±26 to 148±22 mm Hg and from 86±14 to 80±11 mm Hg, respectively; P <0.05), and blood pressure control was more facile in approximately half of the patients. Creatinine decreased or remained stable in approximately two thirds of the patients. The cumulative probability of survival was 74±4% at 3 years, with few deaths related to end-stage renal disease. Survival was good in patients with normal (92±4%) baseline renal function, fair (74±7%) in those with mildly impaired renal function, and poor (52±7%) in patients with elevated baseline creatinine levels (≥2.0 mg/dL). The combination of impaired renal function and bilateral disease adversely affected survival. Conclusions —Renal artery stent revascularization in the presence of normal or mildly impaired renal function had a beneficial effect on blood pressure control and a nondeleterious effect on renal function. Survival was adversely affected by renal dysfunction despite adequate revascularization. Early diagnosis and adequate revascularization before the onset of renal dysfunction could beneficially affect blood pressure control, preserve or prevent deterioration of renal function, and improve patient survival.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Cited by 328 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3